Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report

Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report

Abstract Background Half of U.S. adults have received at least one dose of the COVID-19 vaccines produced by either Pfizer, Moderna, or Johnson and Johnson, which represents a major milestone in the ongoing pandemic. Given the emergency use authorizations for these vaccines, their side effects and s...

Full description

Bibliographic Details
Main Authors: Ammar A. Hasnie, Usman A. Hasnie, Nirav Patel, Muhammad U. Aziz, Min Xie, Steven G. Lloyd, Sumanth D. Prabhu
Format: Article
Language:English
Published: BMC 2021-08-01
Series:BMC Cardiovascular Disorders
Subjects:
COVID-19
Myopericarditis
Cardiac MRI
ECG
Case report
Online Access:https://doi.org/10.1186/s12872-021-02183-3

Internet

https://doi.org/10.1186/s12872-021-02183-3

Similar Items